Commentary: absolute and relative contraindications to pegylated-interferon or ribavirin in the US general patient population with chronic hepatitis C--authors' reply.
State University of New York, Buffalo, NY, USA. ahtalal@buffalo.edu
A H
AH
Talal
J
J
Lafleur
R S
RS
Hoop
P
P
Pandya
P
P
Martin
I M
IM
Jacobson
J
J
Han
E J
EJ
Korner
D000998:Antiviral Agents; D000075202:Contraindications; D005260:Female; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D016898:Interferon-alpha; D008297:Male; D011092:Polyethylene Glycols; D012254:Ribavirin
D000998:Antiviral Agents; D016898:Interferon-alpha; D011092:Polyethylene Glycols; D012254:Ribavirin